J. Payen, G. Francony, C. Canet, F. Coppo, and B. Fauvage, Neuros??dation en r??animation, Annales Fran??aises d'Anesth??sie et de R??animation, vol.28, issue.12, pp.1015-1024, 2009.
DOI : 10.1016/j.annfar.2009.10.003

C. Mckenzie, W. Mckinnon, D. Naughton, D. Treacher, G. Davies et al., Differentiating midazolam over-sedation from neurological damage in the intensive care unit, Critical Care, vol.9, issue.1, pp.32-38, 2005.
DOI : 10.1186/cc3010

N. Bruder, D. Lassegue, D. Pelissier, N. Graziani, and G. Francois, Energy expenditure and withdrawal of sedation in severe head-injured patients, Critical Care Medicine, vol.22, issue.7, pp.1114-1123, 1994.
DOI : 10.1097/00003246-199407000-00011

W. Cammarano, J. Pittet, S. Weitz, R. Schlobohm, and J. Marks, Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients, Critical Care Medicine, vol.26, issue.4, pp.676-84, 1998.
DOI : 10.1097/00003246-199804000-00015

J. Jacobi, G. Fraser, D. Coursin, R. Riker, D. Fontaine et al., Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult, Critical Care Medicine, vol.30, issue.1, pp.119-160, 2002.
DOI : 10.1097/00003246-200201000-00020

R. Chiolero and P. Schoettker, Arr??t de la s??dation en neuror??animation, Annales Fran??aises d'Anesth??sie et de R??animation, vol.23, issue.5, pp.541-546, 2004.
DOI : 10.1016/j.annfar.2004.01.011

J. Tobias, Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit, Critical Care Medicine, vol.28, issue.6, pp.2122-2154, 2000.
DOI : 10.1097/00003246-200006000-00079

M. Saito, Y. Terao, M. Fukusaki, T. Makita, O. Shibata et al., Sequential Use of Midazolam and Propofol for Long-Term Sedation in Postoperative Mechanically Ventilated Patients, Anesthesia & Analgesia, vol.96, pp.834-842, 2003.
DOI : 10.1213/01.ANE.0000048714.01230.75

D. Liatsi, B. Tsapas, S. Pampori, M. Tsagourias, I. Pneumatikos et al., Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome, Intensive Care Medicine, vol.155, issue.2, pp.275-81, 2009.
DOI : 10.1007/s00134-008-1251-0

M. Reade, O. Sullivan, K. Bates, S. Goldsmith, D. Ainslie et al., Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial, Critical Care, vol.13, issue.3, p.75, 2009.
DOI : 10.1186/cc7890

J. Payen, O. Bru, J. Bosson, A. Lagrasta, E. Novel et al., Assessing pain in critically ill sedated patients by using a behavioral pain scale, Critical Care Medicine, vol.29, issue.12, pp.2258-63, 2001.
DOI : 10.1097/00003246-200112000-00004

R. Riker, J. Picard, and G. Fraser, Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients, Critical Care Medicine, vol.27, issue.7, pp.1325-1334, 1999.
DOI : 10.1097/00003246-199907000-00022

J. Payen, J. Mantz, D. Jonghe, and B. , Arrêt de la sé dation In: Sfar, editor. Confé rences d'actualisation 50 e Congrè s national d'anesthé sie et de ré animation, pp.247-59, 2008.

T. Kosten, O. Connor, and P. , Management of Drug and Alcohol Withdrawal, New England Journal of Medicine, vol.348, issue.18, pp.1786-95, 2003.
DOI : 10.1056/NEJMra020617

L. Gowing, R. Ali, and J. White, Buprenorphine for the management of opioid withdrawal, Cochrane Database Syst Rev, p.2025, 2006.

M. Korak-leiter, R. Likar, M. Oher, E. Trampitsch, G. Ziervogel et al., Withdrawal following sufentanil/propofol and sufentanil/midazolam, Intensive Care Medicine, vol.91, issue.3, pp.380-387, 2005.
DOI : 10.1007/s00134-005-2579-3

W. Koppert, H. Ihmsen, N. Korber, A. Wehrfritz, R. Sittl et al., Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model, Pain, vol.118, issue.1, pp.15-22, 2005.
DOI : 10.1016/j.pain.2005.06.030

T. Vanderah, L. Gardell, S. Burgess, M. Ibrahim, A. Dogrul et al., Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance, J Neurosci, vol.20, pp.7074-7083, 2000.

V. Lelong-boulouard, T. Quentin, F. Moreaux, D. Debruyne, M. Boulouard et al., Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse, Drug and Alcohol Dependence, vol.85, issue.2, pp.103-116, 2006.
DOI : 10.1016/j.drugalcdep.2006.03.017
URL : https://hal.archives-ouvertes.fr/hal-00865382

T. Quentin, D. Debruyne, V. Lelong-boulouard, G. Poisnel, L. Barre et al., Clorazepate affects cell surface regulation of ?? and ?? opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain, Brain Research, vol.1063, issue.1, pp.84-95, 2005.
DOI : 10.1016/j.brainres.2005.09.013